Cargando…
Incorporation of functional elements enhances the antitumor capacity of CAR T cells
As chimeric antigen receptor (CAR) T cells have displayed an unprecedented efficacy in the treatment of CD19-positive malignances, it is believed that this cell therapy will be a milestone in the history of mankind’s conquering of cancer. However, there are some issues that restrict CAR T cells from...
Autores principales: | Qin, Le, Zhao, Ruocong, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637271/ https://www.ncbi.nlm.nih.gov/pubmed/29046826 http://dx.doi.org/10.1186/s40164-017-0088-z |
Ejemplares similares
-
Current status and hurdles for CAR-T cell immune therapy
por: Zhao, Ruocong, et al.
Publicado: (2019) -
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
por: Zhang, Qian, et al.
Publicado: (2021) -
Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer
por: Zhao, Ruocong, et al.
Publicado: (2021) -
CAR-T design: Elements and their synergistic function
por: Jayaraman, Jayapriya, et al.
Publicado: (2020) -
Arming NK cells with enhanced antitumor activity: CARs and beyond
por: Oberoi, Pranav, et al.
Publicado: (2013)